Indefinite Delivery Contract HHSN263200400061816I
Award Date
9/21/04
Last Date to Order
9/20/07
Funding Federal Agency
Not listed
Contracting Federal Agency
Office of the Director
Awardee
Myriad Genetic Laboratories Inc.
Ultimate Awardee
Myriad Genetics Inc.
PSC Category
Q301 - Reference Laboratory Testing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Other Statutory Authority
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to the Sloan-Kettering Institute for Cancer Research, a non-profit organization. The contract, valued at $236,000.00, is part of the NCI Cancer Genome Atlas (TCGA) Program and aims to procure tissue samples and data from various cancer types for the TCGA's comprehensive genomic characterization efforts.
The contract was awarded in...
This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to the non-profit organization Health Research, Inc. (HRI). The contract, valued at $765,306, supports the Cancer Genome Atlas (TCGA) program by providing tissue samples and data from various cancer types for genomic characterization.
Under the contract, HRI's Roswell Park Division, doing business...
This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to the Sloan-Kettering Institute for Cancer Research, a non-profit organization located in New York, NY. The contract, valued at $200,000, supports the NCI's Cancer Genome Atlas (TCGA) program, which aims to collect and analyze tissue samples and data from various cancer types.
The initial $120,500 task order under this contract requires the...
This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a civilian agency, to the Sloan-Kettering Institute for Cancer Research, a non-profit organization. The $550,000 single-award contract is part of the NCI Cancer Genome Atlas Program Tissue Purchase master contract and aims to procure tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program.
Under a $488,000 delivery order, Sloan-Kettering Institute for Cancer Research,...
This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Indivumed, Inc. to provide tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program. The contract has a total ceiling value of $2,712,155.00 and does not have a set-aside designation.
The contract consists of three firm-fixed-price delivery orders with a combined total value of $2,259,118.07....
This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to Cedars-Sinai Medical Center, a nonprofit hospital and academic medical center located in Los Angeles. The $22,113 contract is for the recovery of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program, which is part of the NCI's efforts related to the American Recovery and Reinvestment Act...
This is an Indefinite Delivery Contract (IDC) awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to Mayo Clinic, a renowned non-profit academic medical center. The contract is part of the NCI Cancer Genome Atlas Program Tissue Purchase IDIQ, with a ceiling value of $100,000.00 and a performance period through September 2014.
Under this firm-fixed price delivery order contract, Mayo Clinic will provide tissue samples and data from...
This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a civilian federal agency, to the Melanoma Institute Australia. The $192,500 firm fixed-price delivery order contract, part of the NCI's Cancer Genome Atlas (TCGA) program, involves the collection of tissue samples and data from various types of cancer. This work was funded under the American Recovery and Reinvestment Act (ARRA) and does not have a set-aside designation. The contract's period of performance...
This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to Mayo Clinic, a renowned non-profit academic medical center. The contract, valued at $130,403.07, supports the NCI's Cancer Genome Atlas (TCGA) program by recovering tissue samples and data from various types of cancer. It is part of a larger $9.9 million NCI Cancer Genome Atlas Program Tissue Purchase indefinite delivery/indefinite quantity (IDIQ) contract, which allows the NCI to efficiently...
This indefinite delivery contract (HHSN261201000043I) was awarded by the National Cancer Institute (NCI) to Mayo Clinic, a renowned non-profit academic medical center, to support the Cancer Genome Atlas (TCGA) program under the American Recovery and Reinvestment Act (ARRA). The contract has a fixed ceiling value of $6,663.53 and a period of performance from June 21, 2010 to August 28, 2013, with no set-aside designation.
Under this delivery order, Mayo Clinic is tasked with recovering tissue...